ACTU vs PEG · $49.0M cap vs P/E 18, rev $10.29B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
ACTU does not have a complete income-statement cache yet.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
ACTU currently screens at market cap $49.0M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the ACTU and PEG stock pages for the full models.
Not investment advice.